The Organ-on-Chip market is experiencing rapid growth as the pharmaceutical industry seeks more effective and human-like testing methods to reduce drug development time and costs. With an increasing number of regulatory agencies supporting new testing approaches and a rising interest in personalized medicine, these advanced microfluidic systems are poised to transform preclinical research by closely mimicking the functions of real human organs